|
|
||||||||
Department of Medicine, Division of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107
Administration of a vaccine consisting of autologous melanoma cells
modified with a hapten, dinitrophenyl (DNP), induces T cell
infiltration of metastatic sites. We have reported an analysis of these
infiltrating T cells, indicating that certain TCR-V
gene
segments are greatly overexpressed. In this study, we investigate the
rearrangement of the TCR-V
as well as the junctional diversity in T
cells infiltrating melanoma metastases following treatment with DNP
vaccine. In 19 of 26 control specimens, V-D-J length analysis showed
the expected polyclonal patterns. In contrast, postvaccine tumors from
9 of 10 patients showed dominant peaks of V-D-J junction size in one or
more V
families. Dominant peaks were seen most frequently in six
V
families (V
7, 12, 13, 14, 16, and 23) and were never seen in
seven others. Further analysis of the oligoclonal V
products showed
dominant peaks in the J region as well. Of particular interest was the
finding that V
and J
peaks were similar in inflamed metastases
obtained at different times or from different sites from the same
patient. Although 6 of 10 patients expressed HLA-A1, there was no
common pattern of TCR rearrangements among them. Finally, the amplified
PCR products from seven of these specimens were cloned and sequenced
and the amino acid sequence of the complementarity-determining
region 3 was deduced. In six of seven specimens, the same
complementarity-determining region 3 sequence was repeated in at least
two clones and in five of seven in at least three clones. Our study
indicates that DNP vaccine induces the expansion of particular T cell
clones that may be agents of its antitumor
effects.
This article has been cited by other articles:
![]() |
J. Zhou, M. E. Dudley, S. A. Rosenberg, and P. F. Robbins Selective Growth, In Vitro and In Vivo, of Individual T Cell Clones from Tumor-Infiltrating Lymphocytes Obtained from Patients with Melanoma J. Immunol., December 15, 2004; 173(12): 7622 - 7629. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Willhauck, C. Scheibenbogen, M. Pawlita, T. Mohler, E. Thiel, and U. Keilholz Restricted T-Cell Receptor Repertoire in Melanoma Metastases Regressing after Cytokine Therapy Cancer Res., July 1, 2003; 63(13): 3483 - 3485. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |